1
Participants
Start Date
March 26, 2019
Primary Completion Date
March 31, 2020
Study Completion Date
March 31, 2020
Cardiovalve Transfemoral Mitral Valve
The Cardiovalve Transfemoral Mitral Valve System is intended for use symptomatic patients with severe mitral regurgitation who are at elevated risk for surgical mitral valve repair or replacement and who are anatomically eligible for transfemoral mitral valve replacement with transseptal access to the left atrium.
Columbia University Medical Center/NYPH, New York
Piedmont Heart Institute, Atlanta
Lead Sponsor
Collaborators (1)
Cardiovalve Ltd.
INDUSTRY
Cardiovascular Research Foundation, New York
OTHER
Boston Biomedical Associates
OTHER